Your browser doesn't support javascript.
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
Polverino, Francesca; Stern, Debra A; Ruocco, Gaetano; Balestro, Elisabetta; Bassetti, Matteo; Candelli, Marcello; Cirillo, Bruno; Contoli, Marco; Corsico, Angelo; D'Amico, Filippo; D'Elia, Emilia; Falco, Giuseppe; Gasparini, Stefano; Guerra, Stefano; Harari, Sergio; Kraft, Monica; Mennella, Luigi; Papi, Alberto; Parrella, Roberto; Pelosi, Paolo; Poletti, Venerino; Polverino, Mario; Tana, Claudio; Terribile, Roberta; Woods, Jason C; Di Marco, Fabiano; Martinez, Fernando D.
  • Polverino F; University of Arizona, Tucson, AZ, United States.
  • Stern DA; Lovelace Respiratroy Research Institute, Albuquerque, NM, United States.
  • Ruocco G; University of Arizona, Tucson, AZ, United States.
  • Balestro E; Regina Montis Regalis Hospital, Mondovì, Italy.
  • Bassetti M; University Hospital of Padua, Padua, Italy.
  • Candelli M; San Martino Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Genoa, Italy.
  • Cirillo B; Agostino Gemelli University Polyclinic, Catholic University of the Sacred Heart, Rome, Italy.
  • Contoli M; Sapienza University of Rome, Rome, Italy.
  • Corsico A; University of Ferrara, Ferrara, Italy.
  • D'Amico F; University of Pavia, Pavia, Italy.
  • D'Elia E; Azienda Socio Sanitaria Territoriale Bergamo EST, Seriate, Italy.
  • Falco G; Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Gasparini S; Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy.
  • Guerra S; Marche Polytechnic University, Ancona, Italy.
  • Harari S; University of Arizona, Tucson, AZ, United States.
  • Kraft M; Department of Medical Sciences, San Giuseppe Hospital MultiMedica IRCCS, Milan, Italy.
  • Mennella L; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Papi A; University of Arizona, Tucson, AZ, United States.
  • Parrella R; San Luca Hospital, Vallo della Lucania, Italy.
  • Pelosi P; University of Ferrara, Ferrara, Italy.
  • Poletti V; Department of Infectious Diseases, Colli Hospital, Naples, Italy.
  • Polverino M; San Martino Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Genoa, Italy.
  • Tana C; L. Pierantoni GB Morganis Hospital, Forlì, Italy.
  • Terribile R; Mauro Scarlato Hospital, Azienda Sanitaria Locale Salerno, Scafati, Italy.
  • Woods JC; ASL Lanciano Vasto Chieti, Chieti, Italy.
  • Di Marco F; University Hospital Major of Charity of Novara, Novara, Italy.
  • Martinez FD; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Front Cardiovasc Med ; 7: 585866, 2020.
Article in English | MEDLINE | ID: covidwho-914408
ABSTRACT

Background:

Italy has one of the world's oldest populations, and suffered one the highest death tolls from Coronavirus disease 2019 (COVID-19) worldwide. Older people with cardiovascular diseases (CVDs), and in particular hypertension, are at higher risk of hospitalization and death for COVID-19. Whether hypertension medications may increase the risk for death in older COVID 19 inpatients at the highest risk for the disease is currently unknown.

Methods:

Data from 5,625 COVID-19 inpatients were manually extracted from medical charts from 61 hospitals across Italy. From the initial 5,625 patients, 3,179 were included in the study as they were either discharged or deceased at the time of the data analysis. Primary outcome was inpatient death or recovery. Mixed effects logistic regression models were adjusted for sex, age, and number of comorbidities, with a random effect for site.

Results:

A large proportion of participating inpatients were ≥65 years old (58%), male (68%), non-smokers (93%) with comorbidities (66%). Each additional comorbidity increased the risk of death by 35% [adjOR = 1.35 (1.2, 1.5) p < 0.001]. Use of ACE inhibitors, ARBs, beta-blockers or Ca-antagonists was not associated with significantly increased risk of death. There was a marginal negative association between ARB use and death, and a marginal positive association between diuretic use and death.

Conclusions:

This Italian nationwide observational study of COVID-19 inpatients, the majority of which ≥65 years old, indicates that there is a linear direct relationship between the number of comorbidities and the risk of death. Among CVDs, hypertension and pre-existing cardiomyopathy were significantly associated with risk of death. The use of hypertension medications reported to be safe in younger cohorts, do not contribute significantly to increased COVID-19 related deaths in an older population that suffered one of the highest death tolls worldwide.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Front Cardiovasc Med Year: 2020 Document Type: Article Affiliation country: Fcvm.2020.585866

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Front Cardiovasc Med Year: 2020 Document Type: Article Affiliation country: Fcvm.2020.585866